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LETTER TO THE EDITOR
A plea for better coding rules for bladder cancer
Sir - We read with interest the article by Gulliford et al. (Br.
J. Cancer (1993) 67, 819-821) describing the reliability of
cancer registry data with respect to 466 bladder cancer cases.
Cancer registry data are found to be reliable, except for
tumour stage. However, the authors do not discuss the item
'behaviour code for neoplasms', the fifth digit of the ICD-O
morphology code (World Health Organisation, 1976). The
behaviour code is an essential item, because it separates
invasive malignancies (behaviour code: >3) from non-invas-
ive malignancies (code: 2).
The coding of bladder cancer is known to be difficult for
cancer registries (Lynch et al., 1991). After 1973, pathologists
and urologists started to define low-grade papillary shaped
tumours as grade 1 noninvasive papillary urothelial cancer.
When this entity is included in the incidence rates of invasive
bladder cancer, time trends in incidence as well as survival
may be biased. In the Eindhoven cancer registry the increase
in bladder cancer incidence between 1975 and 1989 appears
to be caused almost entirely by this change in classification of
noninvasive bladder cancer (Kiemeney et al., 1993). Although
pathology reports and clinical records may not always be
conclusive, the behaviour code of the ICD-O enables to code
papillary non-invasive urothelial cancers as 8130/2, and the
invasive (papillary) urothelial cancers as e.g., 8130/3, and the
flat in situ bladder cancers as 8010/2. The third edition of the
TNM (International Union against Cancer, 1978) offers
another opportunity for distinction between the papillary
non-invasive (TA) and the invasive bladder cancers (T,+).
From Table II and Table III of the article of Gulliford et
al. we conclude that the Thames Cancer registry codes all
non-invasive bladder cancers as 8130/3 and thus as invasive
malignancies. Table III indicates that this applies to as much
as 46% of all bladder cancer cases (the reviewers coded 154
of 335 bladder cancer cases with a known stage as TA).
Through the inadequate use of the behaviour code and
through the use of a simplified staging system, the Thames
Cancer Registry loses the ability to separate invasive from
non-invasive bladder cancer. This may lead to biased inter-
pretations of observed trends in incidence and survival. Fur-
thermore, it may hamper comparisons between different
cancer registries. Proper use of the behaviour code of the
ICD-0 and usage of the TNM staging system will prevent
cancer registries for such difficulties.
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